Xian Medical: Flat Trading, Strategic Shift Toward High‑Margin Drugs & Investor Focus
Xian Medical’s flat 2026 trading, 0.47% month‑to‑date gain, and analyst focus on its shift to differentiated high‑margin drugs and operational upgrades signal potential long‑term upside for investors.
3 minutes to read



